HCG11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.954800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.796800E-01
Normal-vs-Stage2
3.058200E-01
Normal-vs-Stage3
1.866000E-01
Normal-vs-Stage4
8.975600E-01
Stage1-vs-Stage2
9.630000E-01
Stage1-vs-Stage3
5.720800E-01
Stage1-vs-Stage4
5.502000E-01
Stage2-vs-Stage3
5.194600E-01
Stage2-vs-Stage4
3.492200E-01
Stage3-vs-Stage4
2.619000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.932000E-01
Normal-vs-AfricanAmerican
8.527600E-01
Normal-vs-Asian
4.160000E-02
Caucasian-vs-AfricanAmerican
2.602000E-01
Caucasian-vs-Asian
9.912400E-02
AfricanAmerican-vs-Asian
3.078000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.824000E-01
Normal-vs-Female
3.335000E-01
Male-vs-Female
6.217400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.033600E-01
Normal-vs-Age(41-60Yrs)
4.940600E-01
Normal-vs-Age(61-80Yrs)
2.340400E-01
Normal-vs-Age(81-100Yrs)
3.379400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.786800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.776400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.417000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.653700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.131800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.879000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.488370E-01
Normal-vs-Daily Drinker
2.778500E-02
Normal-vs-Weekly Drinker
1.077960E-01
Normal-vs-Occasional Drinker
5.330000E-01
Normal-vs-Social Drinker
5.971000E-01
Non Drinker-vs-Daily Drinker
4.703200E-01
Non Drinker-vs-Weekly Drinker
6.205000E-01
Non Drinker-vs-Occasional Drinker
1.655230E-01
Non Drinker-vs-Social Drinker
1.849190E-01
Daily Drinker-vs-Weekly Drinker
1.583250E-01
Daily Drinker-vs-Occasional Drinker
5.311600E-02
Daily Drinker-vs-Social Drinker
8.874000E-02
Weekly Drinker-vs-Occasional Drinker
3.440000E-01
Weekly Drinker-vs-Social Drinker
3.841400E-01
Occasional Drinker-vs-Social Drinker
9.550400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.336600E-01
Normal-vs-Grade 2
1.583200E-01
Normal-vs-Grade 3
1.372560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.726640E-01
Grade 1-vs-Grade 3
2.201200E-01
Grade 1-vs-Grade 4
4.336600E-01
Grade 2-vs-Grade 3
9.940000E-01
Grade 2-vs-Grade 4
1.583200E-01
Grade 3-vs-Grade 4
1.372560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.504560E-01
Normal-vs-NonDiabetic
2.124600E-01
Diabetic-vs-NonDiabetic
9.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.718590E-01
Normal-vs-NoPancreatitis
2.308600E-01
Pancreatitis-vs-NoPancreatitis
6.273200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.049800E-01
Normal-vs-N1
3.286200E-01
N0-vs-N1
5.489800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.747400E-01
Normal-vs-TP53-NonMutant
5.367000E-01
TP53-Mutant-vs-TP53-NonMutant
9.864400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
